Combination vaccines containing a monocomponent acellular pertussis (aP) vaccine,
manufactured at Statens Serum Institut (SSI), Denmark, have successfully controlled …

OBJECTIVE: To assess the risk of pertussis by time since vaccination in children in
Minnesota and Oregon who received 5 doses of acellular pertussis vaccines (DTaP) …

Pertussis is a truly unique contagious respiratory disease [1–4]. It is mainly caused by
Bordetella pertussis, but similar cough illnesses can be caused by B. parapertussis in young …

Bordetella pertussis is a Gram-negative human-restricted bacterium that evolved from the
broad-range mammalian pathogen, Bordetella bronchiseptica. It causes whooping cough or …

A large pertussis epidemic occurred between 2008 and 2010 in Japan. To investigate
epidemic strains, we analyzed 33 Bordetella pertussis isolates from the epidemic period by …

Background Pertussis has resurged in the Netherlands since 1996. Several measures, ie
acceleration of the schedule, introduction of a preschool acellular pertussis booster and …

Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, which is a
highly contagious disease in the human respiratory tract. Despite vaccination since the …

Pertussis is a highly infectious respiratory disease that is currently responsible for nearly
300,000 annual deaths worldwide, primarily in infants in developing countries. Despite …

Whooping cough is a respiratory illness most severe in infants and young children. While the
introduction of whole-cell (wP) and acellular pertussis (aP) vaccines has greatly reduced the …

Bordetella parapertussis, a close related species of B. pertussis, can also cause the disease
named pertussis or whooping cough. The number of cases caused by this related pathogen …